Citation: | LU Sheng, WU Wei, HOU Dongsheng, ZHU Xiaocheng, YAO Libin, HONG Jian, SHAO Yong. Comparison of effectiveness and nutritional condition in obese T2DM rats after sleeve gastrectomy-transit bipartition and biliopancreatic diversion with duodenal switch[J]. Journal of Xuzhou Medical University, 2022, 42(7): 478-483. DOI: 10.3969/j.issn.2096-3882.2022.07.002 |
[1] |
Piché ME, Tchernof A, Després JP.Obesity phenotypes, diabetes, and cardiovascular diseases[J].Circ Res, 2020, 126(11):1477-1500.
|
[2] |
Seravalle G, Grassi G.Obesity and hypertension[J].Pharmacol Res, 2017, 122:1-7.
|
[3] |
Kolotkin RL, Meter K, Williams GR.Quality of life and obesity[J].Obes Rev, 2001, 2(4):219-229.
|
[4] |
李梦伊, 刘洋, 赵象文, 等.大华北减重与代谢手术临床资料数据库2019年度报告[J].中国实用外科杂志, 2020, 40(4):418-425.
|
[5] |
Yu J, Zhou X, Li L, et al.The long-term effects of bariatric surgery for type 2 diabetes:systematic review and meta-analysis of randomized and non-randomized evidence[J].Obes Surg, 2015, 25(1):143-158.
|
[6] |
Strain GW, Torghabeh MH, Gagner M, et al.The impact of biliopancreatic diversion with duodenal switch (BPD/DS) over 9 years[J].Obes Surg, 2017, 27(3):787-794.
|
[7] |
Sorribas M, Casajoana A, Sobrino L, et al.Experience in biliopancreatic diversion with duodenal switch:Results at 2, 5 and 10 years[J].Cir Esp (Engl Ed), 2022, 100(4):202-208.
|
[8] |
Topart PA, Becouarn G.Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss:a review of the current literature on indications and procedures[J].Surg Obes Relat Dis, 2015, 11(4):965-972.
|
[9] |
Alalwan AA, Friedman J, Park H, et al.US national trends in bariatric surgery:A decade of study[J].Surgery, 2021, 170(1):13-17.
|
[10] |
AI M, Taskin HE.Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity:early effectiveness and safety outcomes[J].Surg Endosc, 2022, 36(4):2631-2642.
|
[11] |
Liu P, Widjaja J, Dolo PR, et al.Comparing the anti-diabetic effect of sleeve gastrectomy with transit bipartition against sleeve gastrectomy and Roux-en-Y gastric bypass using a diabetic rodent model[J].Obesity surgery, 2021, 31(5):2203-2210.
|
[12] |
Biertho L, Simon-Hould F, Marceau S, et al.Current outcomes of laparoscopic duodenal switch[J/OL].Ann Surg Innov Res, 2016, 10:1.
|
[13] |
Risstad H, Søvik TT, Engström M, et al.Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60:a randomized clinical trial[J].JAMA surgery, 2015, 150(4):352-361.
|
[14] |
Biertho L, Lebel S, Marceau S, et al.Biliopancreatic diversion with duodenal switch:surgical technique and perioperative care[J].Surg Clin North Am, 2016, 96(4):815-826.
|
[15] |
Mingrone G, Castagneto-Gissey L.Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery[J].Diabetes Metab, 2009, 35(6 Pt 2):518-523.
|
[16] |
Sandoval D.CNS GLP-1 regulation of peripheral glucose homeostasis [J].Physiol Behav, 2008, 94(5):670-674.
|
[17] |
Buteau J.GLP-1 receptor signaling:effects on pancreatic beta-cell proliferation and survival [J].Diabetes Metab, 2008, Suppl 2:S73-S77.
|
[18] |
Topart P, Becouarn G, Finel JB.Comparison of 2-year results of Roux-en-Y gastric bypass and transit bipartition with sleeve gastrectomy for superobesity[J].Obes Surg, 2020, 30(9):3402-3407.
|